Viewing nowMD Esopark Tablet 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Ari Pharmaceutical Co., Ltd.

MFDS item code 201604558 · Approved 2016.07.22 · Insurance code 058200060
Treatment of gastroesophageal reflux disease, gastrointestinal disorders (such as ulcers and Helicobacter pylori infection), and Zollinger-Ellison syndrome
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, and is effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. In addition, it helps relieve symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment of duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection, and is crucial for preventing recurrence. It is used short-term to treat upper gastrointestinal symptoms related to NSAID use and helps treat and prevent gastric ulcers and duodenal ulcers that may occur due to such therapy. It is also used for treating Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding after intravenous administration. Thus, it is widely used for the treatment and prevention of various gastrointestinal disorders.
This drug should be swallowed with a liquid such as water; do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the drug for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms are relieved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of gastric and duodenal ulcers due to use of nonsteroidal anti-inflammatory drugs. 2) Antibiotic combination therapy for eradication of Helicobacter pylori Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg, 2 times daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with use of nonsteroidal anti-inflammatory drugs (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials exceeding 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with use of nonsteroidal anti-inflammatory drugs: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg 2 times daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this drug to patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this drug. 6. Older adults No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis is not healed or symptoms persist, continue taking the drug for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms are relieved, control subsequent symptoms by administering 20 mg once daily. 3. Children under 12 years There is no experience with administering this drug to children under 12 years.
This medication should not be used in certain patients. For instance, it should not be administered to patients who are allergic to this drug or its components, those with hypersensitivity to penicillin and macrolide antibiotics, patients taking certain heart-related medications, nursing women, or those with a history of myocardial infarction. This medication contains the dye Yellow No. 5, so caution should be exercised if there is a history of allergy or hypersensitivity to this dye. Various adverse reactions may occur with this medication, including headaches, dizziness, abdominal pain, diarrhea, skin rashes, muscle pain, and liver function abnormalities. Rarely, serious blood disorders or allergic reactions, hepatitis, and severe skin reactions may occur, and if any unusual symptoms occur, medical consultation should be sought immediately. Due to its acid-suppressive action, this medication can affect the normal bacterial balance in the stomach, increasing the risk of intestinal infections. Patients in a hospital setting should be especially cautious of Clostridium difficile infections. Prolonged use may lead to increased fracture risk and side effects such as hypomagnesemia, so regular monitoring is necessary. Hypomagnesemia can lead to cardiac arrhythmias or muscle symptoms, requiring caution. This medication may interact with various medicines, particularly those affecting blood coagulation such as warfarin, antiviral agents, certain antibiotics, and anticonvulsants. Therefore, medical guidance should be followed. The safety of this medication during pregnancy has not been sufficiently established, so pregnant women should use it cautiously after consulting their physician. Nursing women are advised to avoid this medication. In the event of overdose, specific antidotes are not available, and appropriate treatment should be administered according to symptoms. This medication is not removed through dialysis. Finally, this medication should be kept out of reach of children, and it is important not to transfer it to another container to ensure safety and quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscular weakness, renal tubulointerstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-related diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid nodules, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonicity, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremors, visual field defects, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbances, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric mucosal polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This helps to safely maintain the medication's effectiveness.
Pale pink rectangular film-coated tablets
28T/Alu-Alu (14T/Alu-Alu*2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Ari Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.